Wandong Medical (600055) 2021 Third Quarter Report Review: Revenue Side Achieves Higher Growth Product Structure Changes Pressure Profit Side
興業證券Nov 3, 2021 00:00
Wandong Medical (600055): Product market demand returns to normal, benefiting from new medical infrastructure in the long term
天風證券Sep 6, 2021 00:00
Wandong Medical (600055) 2020 Annual Report and 2021 Quarterly Report Reviews: Mobile DR Drives Full-Year 2020 Growth, 21Q1 Performance Is Under Strong Pressure
興業證券Apr 30, 2021 00:00
万东医疗(600055):DR类产品需求贯穿全年 常规产品业绩逐步回暖
興業證券Nov 2, 2020 00:00
Wandong Medical (600055): improved month-on-month ratio of conventional products
華泰證券Oct 29, 2020 00:00
万东医疗(600055):Q3营收同比下降 长期受益于医疗新基建
國元證券Oct 29, 2020 00:00
万东医疗(600055)2020中报点评:抗疫相关产品实现高增长 其他产品业绩逐步回暖
興業證券Aug 24, 2020 00:00
Wandong Medical (600055): high performance growth is expected to benefit from the policy of increasing medical equipment configuration certificates.
中信建投證券Aug 23, 2020 00:00
万东医疗(600055)2020半年报点评:抗疫DR表现亮眼 毛利率提升明显
國元證券Aug 23, 2020 00:00
Wandong Medical (600055): anti-epidemic products shine brilliantly
華泰證券Aug 21, 2020 00:00
万东医疗(600055):DR及移动DR持续靓丽
華泰證券Jul 2, 2020 00:00
万东医疗(600055)2019年年报及2020年一季报点评:抗疫产品Q1高增长 产品结构持续升级
興業證券May 5, 2020 00:00
万东医疗(600055)年报点评报告:2019业绩稳健增长 受疫情影响2020Q1利润剧增
天風證券May 2, 2020 00:00
Wandong Medical (600055): Rapid growth in performance in the first quarter, new infrastructure further boosts equipment demand
中信建投證券Apr 29, 2020 00:00
万东医疗(600055)年报点评:2019表现平稳 疫情推动影像诊断产品需求
平安證券Apr 29, 2020 00:00
Wandong Medical (600055): Continued improvement in operating efficiency in 2019, outstanding performance in 2020 Q1
西南證券Apr 28, 2020 00:00
Wandong Healthcare (600055) 2019 Report and 2020Q1 Quarterly Report Review: The epidemic has surged, mobile DR demand has performed well
國元證券Apr 28, 2020 00:00
Wandong Medical (600055): the whole product line layout of medical image scarcity has a broad prospect.
西南證券Mar 24, 2020 00:00
万东医疗(600055):抗疫先锋 移动DR勇担大任
華泰證券Feb 17, 2020 00:00
万东医疗(600055):外资投资评级(FIR)
中盛在線Jan 10, 2020 00:00
No Data
No Data